Since PAK1 can also regulate cell transformation and survival and because of increased frequency of phosphorylation observed in poor outcome tumors [16], the PAK signaling pathway could therefore constitute a major effector pathway of Rac1/Cdc42 in prostate cancer cells. This evidence concerns the gene CDC42 and prostate carcinoma.